BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12955664)

  • 1. A case of Leuconostoc ventriculitis with resistance to carbapenem antibiotics.
    Deye G; Lewis J; Patterson J; Jorgensen J
    Clin Infect Dis; 2003 Sep; 37(6):869-70. PubMed ID: 12955664
    [No Abstract]   [Full Text] [Related]  

  • 2. Leuconostoc species-associated endocarditis.
    Starr JA
    Pharmacotherapy; 2007 May; 27(5):766-70. PubMed ID: 17461713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem resistance in Bacteroides fragilis.
    Ang L; Brenwald NP; Walker RM; Andrews J; Fraise A
    J Antimicrob Chemother; 2007 May; 59(5):1042-4. PubMed ID: 17363423
    [No Abstract]   [Full Text] [Related]  

  • 4. [Leuconostoc sp in cancer patients: a descriptive study].
    Cuervo M SI; Cortés L J; Rodríguez R E; Hormaza A N; Vargas S E
    Rev Chilena Infectol; 2008 Jun; 25(3):184-8. PubMed ID: 18580995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Song JY; Lee J; Heo JY; Noh JY; Kim WJ; Cheong HJ; Hwang IS
    Int J Antimicrob Agents; 2008 Sep; 32(3):281-4. PubMed ID: 18650070
    [No Abstract]   [Full Text] [Related]  

  • 6. Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis.
    Metan G; Alp E; Aygen B; Sumerkan B
    Int J Antimicrob Agents; 2007 Jan; 29(1):112-3. PubMed ID: 17134880
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of Pseudomonas aeruginosa.
    Tam VH; Chang KT; LaRocco MT; Schilling AN; McCauley SK; Poole K; Garey KW
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):309-14. PubMed ID: 17617302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First report of the carbapenem-resistant Pseudomonas aeruginosa producing IMP-7 metallo-beta-lactamase in Slovakia.
    Ohlasova D; Kmet V; Niks M
    Int J Antimicrob Agents; 2007 Oct; 30(4):370-1. PubMed ID: 17709230
    [No Abstract]   [Full Text] [Related]  

  • 9. Spread of low-level carbapenem-resistant Acinetobacter baumannii clones in a tertiary care Greek hospital.
    Tsakris A; Tsioni C; Pournaras S; Polyzos S; Maniatis AN; Sofianou D
    J Antimicrob Chemother; 2003 Dec; 52(6):1046-7. PubMed ID: 14585857
    [No Abstract]   [Full Text] [Related]  

  • 10. [Carbapenem resistance determined by metalloenzymes in clinical isolates of Pseudomonas aeruginosa].
    Sánchez A; Salso S; Culebras E; Picazo JJ
    Rev Esp Quimioter; 2004 Dec; 17(4):336-40. PubMed ID: 15696224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy.
    Wolter DJ; Acquazzino D; Goering RV; Sammut P; Khalaf N; Hanson ND
    Clin Infect Dis; 2008 Jun; 46(12):e137-41. PubMed ID: 18462098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance.
    Metan G; Alp E; Aygen B; Sumerkan B
    J Antimicrob Chemother; 2007 Jul; 60(1):197-9. PubMed ID: 17540668
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance of enterobacteria to carbapenem antibiotics is a global crisis.
    Tanne JH
    BMJ; 2012 Mar; 344():e1646. PubMed ID: 22396112
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro activity of tigecycline against carbapenem-susceptible and -resistant isolates of Klebsiella spp. and Enterobacter spp.
    Woodford N; Hill RL; Livermore DM
    J Antimicrob Chemother; 2007 Mar; 59(3):582-3. PubMed ID: 17229831
    [No Abstract]   [Full Text] [Related]  

  • 15. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City.
    Bradford PA; Bratu S; Urban C; Visalli M; Mariano N; Landman D; Rahal JJ; Brooks S; Cebular S; Quale J
    Clin Infect Dis; 2004 Jul; 39(1):55-60. PubMed ID: 15206053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
    Poirel L; Nordmann P
    Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leuconostoc, an emerging vancomycin-resistant pathogen.
    Horowitz HW; Handwerger S; van Horn KG; Wormser GP
    Lancet; 1987 Dec; 2(8571):1329-30. PubMed ID: 2890924
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
    McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR
    J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leuconostoc spp sepsis in an extremely low birth weight infant: a case report and review of the literature.
    Yossuck P; Miller-Canfield P; Moffett K; Graeber J
    W V Med J; 2009; 105(5):24-7. PubMed ID: 19806867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.